Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5
October 30 2020 - 7:00AM
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage
biopharmaceutical company developing next-generation programmed T
cell therapies, today announced that it will release its third
quarter 2020 financial results and operational highlights before
open of U.S. markets on Thursday, November 5, 2020.
Management will host a conference call and
webcast at 8:30 am ET/1:30 pm GMT to discuss the company’s
financial results and provide a general business update. To listen
to the webcast and view the accompanying slide presentation, please
go
to: https://www.autolus.com/investor-relations/news-and-events/events.
The call may also be accessed by dialing (866)
679 5407 for U.S. and Canada callers or (409) 217-8320 for
international callers. Please reference conference ID 5562455.
After the conference call, a replay will be available for one week.
To access the replay, please dial (855) 859-2056 for U.S. and
Canada callers or (404) 537-3406 for international callers. Please
reference conference ID 5562455.
Contact:
Lucinda Crabtree, PhDVice President, Investor
Relations and Corporate Communications+44 (0) 7587 372
619l.crabtree@autolus.com
Julia Wilson+44 (0) 7818
430877j.wilson@autolus.com
Susan A. NoonanS.A. Noonan
Communications+1-212-966-3650susan@sanoonan.com
Autolus Therapeutics (NASDAQ:AUTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Autolus Therapeutics (NASDAQ:AUTL)
Historical Stock Chart
From Apr 2023 to Apr 2024